Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer.

Martina Catalano,Monica Ramello,Raffaele Conca,Giuseppe Aprile,Roberto Petrioli,Giandomenico Roviello

Oncology（2022）

引用 1|浏览9

暂无评分

摘要

Our study confirms age and the number of chemotherapy cycles as CIPN risk factors. The identification and validation of different risk factors could be advantageous to prevent or optimize management of CIPN which outstandingly affect the patient's quality of life.

查看译文

关键词

Chemotherapy-induced peripheral neuropathy,Chemotherapy-induced peripheral neuropathy risk factors,Metastatic pancreatic cancer,Nab-paclitaxel plus gemcitabine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要